Skip to main content

Table 3 Antimicrobial resistance among Salmonella and Shigella isolates by serovars

From: Prevalence and antibiotic resistance of bacterial pathogens isolated from childhood diarrhea in Beijing, China (2010–2014)

Antimicrobial

No. (%) resistance of Salmonella species

No. (%) resistance of Shigella species

S. enteritidis (n = 35)

S. typhimurium (n = 15)

1, 4, [5], 12:i:- (n = 13)

S. agona (n = 10)

Overall (n = 109)

S. sonnei (n = 32)

S. flexneri (n = 4)

S. dysenteriae (n = 1)

Overall (n = 37)

AMP

21 (60.0)

12 (80.0)

11 (84.6)

1 (10.0)

51 (46.8)

31 (96.9)

4 (100.0)

0 (0.0)

35 (94.6)

CHL

3 (8.6)

8 (53.3)

4 (30.8)

1 (10.0)

18 (16.5)

2 (6.3)

4 (100.0)

0 (0.0)

6 (16.2)

CIP

1 (2.9)

6 (40.0)

3 (23.1)

0 (0.0)

10 (9.2)

0 (0.0)

1 (25.0)

0 (0.0)

1 (2.7)

CRO

7 (20.0)

0 (0.0)

2 (15.4)

0 (0.0)

10 (9.2)

10 (31.3)

1 (25.0)

0 (0.0)

11 (29.7)

GEN

3 (8.6)

7 (46.7)

3 (23.1)

1 (10.0)

14 (12.8)

30 (93.8)

0 (0.0)

0 (0.0)

30 (81.1)

NAL

34 (97.1)

9 (60.0)

5 (38.5)

1 (10.0)

61 (56.0)

32 (100.0)

4 (100.0)

0 (0.0)

36 (97.3)

STR

15 (42.9)

10 (66.7)

12 (92.3)

2 (20.0)

48 (44.0)

32 (100.0)

4 (100.0)

1 (100.0)

37 (100.0)

SUL

19 (54.3)

12 (80.0)

9 (69.2)

2 (20.0)

60 (55.0)

32 (100.0)

1 (25.0)

1 (100.0)

34 (91.9)

TET

7 (20.0)

10 (66.7)

10 (76.9)

1 (10.0)

32 (29.4)

12 (37.5)

4 (100.0)

1 (100.0)

17 (45.9)

Multidrug-resistance (MDR)

 MDR3

22 (62.9)

12 (80.0)

11 (84.6)

1 (10.0)

54 (50.0)

32 (100)

4 (100.0)

1 (100)

37 (100)

 MDR4

17 (48.6)

12 (80.0)

9 (69.2)

1 (10.0)

45 (41.3)

31 (96.9)

4 (100.0)

0 (0.0)

35 (94.6)

 MDR5

7 (20.0)

10 (66.7)

5 (38.5)

1 (10.0)

25 (22.9)

31 (96.9)

4 (100.0)

0 (0.0)

35 (94.6)

 MDR6

2 (5.7)

7 (46.7)

4 (30.8)

1 (10.0)

14 (12.8)

18 (56.3)

3 (75.0)

0 (0.0)

21 (56.8)

  1. For 109 Salmonella isolates, two dominant resistance patterns are AMP-STR-SUL-TET (n = 7, 6.4 %) and AMP-STR-SUL-NAL (n = 6, 5.5 %)
  2. For 37 Shigella isolates, two dominant resistant patternsare AMP-GEN-NAL-STR-SUL (n = 12, 32.4 %) and AMP-GEN-NAL-STR-SUL-TET (n = 8, 21.6 %)
  3. AMP ampicillin, CRO ceftriaxone, CIP ciprofloxacin, NAL nalidixic acid, TET tetracycline, GEN gentamicin, CHL chloramphenicol, SUL sulfisoxazole, STR streptomycin, MDR3 resistance to any three antibiotics, MDR4 resistance to any four antibiotics and so on